Radiance Biopharma, Inc. a biotechnology company developing next generation Antibody Drug Conjugates (“ADCs”) and Bispecific ADCs (“BsADCs), announced that it has been selected to participate in Seed ...
This second round followed the success of the inaugural round of the exploratory seed fund call in 2022 (focusing on digital humanities and sustainability) which demonstrated its impact by fostering ...